1-1 of 1
Lukas Veltmaat
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tyrosine kinase inhibitor for CML: all the same?

Clinical Trials & Observations
Lukas Veltmaat, Jorge Cortes
Journal: Blood Advances
Blood Adv (2024) 8 (20): 5339–5341.
https://doi.org/10.1182/bloodadvances.2024014060
Published: 2024